Type-IA variations: questions and answers
Submitted by Anonymous (not verified) on 13 November 2023 - 14:44
Type-IA variations: questions and answers
Worksharing: questions and answers
Submitted by Anonymous (not verified) on 13 November 2023 - 14:44
Worksharing: questions and answers
Pre-authorisation guidance
Submitted by Anonymous (not verified) on 13 November 2023 - 14:44
Pre-authorisation guidance
European Medicines Agency post-authorisation procedural advice for users of the centralised procedure: document with track changes
Submitted by Anonymous (not verified) on 13 November 2023 - 14:38
European Medicines Agency post-authorisation procedural advice for users of the centralised procedure: document with track changes
European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure: document with tracked changes
Submitted by Anonymous (not verified) on 13 November 2023 - 14:33
European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure: document with tracked changes
European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure
Submitted by Anonymous (not verified) on 13 November 2023 - 14:32
European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure
Grouping of variations: questions and answers
Submitted by Anonymous (not verified) on 13 November 2023 - 14:14
Grouping of variations: questions and answers
European Medicines Agency post-authorisation procedural advice for users of the centralised procedure
Submitted by Anonymous (not verified) on 13 November 2023 - 14:13
European Medicines Agency post-authorisation procedural advice for users of the centralised procedure
Multilateral coalitions and initiatives
Submitted by Anonymous (not verified) on 13 November 2023 - 13:57
Multilateral coalitions and initiatives
Opinion/decision on a Paediatric investigation plan (PIP): Delstrigo,doravirine,lamivudine,tenofovir disoproxil (fumarate), decision type: , therapeutic area: , PIP number: P/0504/2022
Submitted by Anonymous (not verified) on 13 November 2023 - 13:38
Opinion/decision on a Paediatric investigation plan (PIP): Delstrigo,doravirine,lamivudine,tenofovir disoproxil (fumarate), decision type: , therapeutic area: , PIP number: P/0504/2022